Healthcare AstraZeneca Beefs Up in Metabolic Illness, Paying $1.2B to P…January 30, 2026 AstraZeneca is increasing its prospects in cardiometabolic illness, paying $1.2 billion to start a partnership on eight applications that embody…
Healthcare FDA Nod Paves Approach for AstraZeneca Drug to Grow to be New Standar…January 19, 2025 A blockbuster AstraZeneca drug could now be used as an earlier remedy for mantle cell lymphoma (MCL), making it the…
